The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of in vitro chemotherapy drug resistance assay to clinical response to carboplatin and paclitaxel combination chemotherapy in ovarian carcinoma.
Kit Cheng
No relevant relationships to disclose
Iuliana Shapira
No relevant relationships to disclose
Lisa M Rosen
No relevant relationships to disclose
Veena S. John
No relevant relationships to disclose
John L. Lovecchio
No relevant relationships to disclose
Andrew Menzin
No relevant relationships to disclose
Jill Suzanne Whyte
No relevant relationships to disclose
Lisa A. Dos Santos
No relevant relationships to disclose
Diana Contreras
No relevant relationships to disclose
Karin Shih
No relevant relationships to disclose
Rajasree Roy
No relevant relationships to disclose
Annette Lee
No relevant relationships to disclose
Christi Hayes
No relevant relationships to disclose
Nazish Ahmad
No relevant relationships to disclose
Pragati Tandon
No relevant relationships to disclose
Mark Allan Hoffman
No relevant relationships to disclose